Le Lézard
Classified in: Mining industry, Oil industry, Science and technology
Subject: PDT

XOS Launches First XRF Benchtop Autosampler with Sample Tracking and Continuous Flow


ALBANY, N.Y., Oct. 17, 2018 /CNW/ -- XOS has announced the worldwide release of Petra Series Autosampler, an automatic sampler with sample tracking and continuous sample loading. The autosampler is an add-on feature to the Petra MAX and Petra 4294 analyzers launched by XOS in 2017.

Visit xos.com/PetraAS to learn more about Petra Series Autosampler.

Michael Palmer, Vice President of Sales for XOS, believes this will deliver the flexible and efficient workflow that users want and need. "After speaking with dozens of customers about the drawbacks of their carousel autosamplers, we created a novel design with sample tracking, continuous sample loading and customizable software features. This is truly the next-generation autosampler."

Typical XRF benchtop automatic sampler systems, often known as a "carousel", require users to manually enter each sample name into the system. This can result in data errors and in turn, rework. In addition, once the carousel has been loaded, it cannot be interrupted until the analyzer has finished analysis. This is not an ideal process for third-party test labs who work in a fast-paced environment and often receive urgent sample requests.

With the new Petra Series Autosampler, users simply scan the QR-coded sample cup with a handheld scanner and the analyzer scans the sample again when it reaches the measurement chamber, ensuring the correct sample name and measurement parameters are paired with results. Users can eliminate data errors and add urgent samples to the queue as needed. The Autosampler is an optional add-on feature and users have the option to use X-ID Sample Cups (QR-coded) or standard XRF cups.

Along with this launch, XOS is rolling out new Gen 4 software upgrade for Petra Series. This release offers novel features for a simple, intuitive operation including preset measurement configurations, streamlined custom calibration set-up, enhanced LIMS compatibility, and additional matrices like water and catalysts.

About XOS
XOS is a leading manufacturer of application-specific X-ray analyzers, offering elemental analysis solutions that improve public safety and customer efficiency in industries like petroleum, consumer products, and environmental compliance. For petroleum applications, XOS offers portable, lab, and process analyzers with unrivaled precision at the push of a button. XOS' advanced optics and OEM sub-systems can increase precision, speed, and spatial resolution, while decreasing the size, complexity, and cost of the instrument. <www.xos.com>

SOURCE XOS


These press releases may also interest you

at 03:50
Today, Nagarro, a global digital engineering leader, presented its audited financial numbers for 2023 and its Annual Report for 2023. FY 2023 shows consistent performance and 6.5% revenue growth. Revenue grew to ?912.1?million in 2023, up from...

at 03:30
At this year's Food4Future Expo, AcoustoFab will introduce a revolutionary breakthrough in the culinary arts leveraging acoustic levitation technology. This technique uses inaudible sound waves to lift and manipulate particles and liquids in mid-air,...

at 03:30
Bloomberg today announced its innovative pricing solution, Intraday BVAL (IBVAL) Front Office, now covers all EUR and GBP investment grade and high yield credit bonds included in Bloomberg's flagship Europe and UK credit indices, and more. New...

at 03:28
OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, has issued updates for April 16, 2024....

at 03:25
Options Technology, a trailblazer in capital markets infrastructure, today announced the appointment of James Hardcastle as Vice President, Head of Sales, Asia Pacific (APAC). With over 25 years of experience in the capital markets industry, James...

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...



News published on and distributed by: